🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 1, single-center, open-label, three subsequent dosing perio...
Status
Completed
Location
Cmax Clinical Research Pty Ltd
Start Date
2018-02-12
Trial ID
NCT03469583
Treatments Being Tested
This is a multicenter, randomized, open-label control trial of two arms con...
Status
Unknown
Location
Huashan Hospital of Fudan University
Start Date
2017-10-25
Trial ID
NCT03448744
Treatments Being Tested
The purpose of this clinical research study is to provide entecavir to subj...
Status
No Longer Available
Location
Local Institution
Start Date
2003-09
Trial ID
NCT00096811
Treatments Being Tested
Entecavir 1 mg is commonly used in patients with chronic hepatitis B (CHB) ...
Status
Unknown
Location
Korea University Ansan Hospital
Start Date
2016-12-01
Trial ID
NCT04069858
Treatments Being Tested
Hepatitis B (HBV) reactivation and hepatitis flare induced by cytotoxic che...
Status
Completed
Location
Taipei Veterans General Hospital-Division of Gastroenterology, Division of Oncology
Start Date
2009-04
Trial ID
NCT00926757
Treatments Being Tested
The aim of this study is to prove the superiority of entecavir over lamivud...
Status
Unknown
Location
Fudan University Cancer Hospital
Start Date
2013-02
Trial ID
NCT01914744
Treatments Being Tested
Background Liver cirrhosis is commonly accompanied by intestinal dysbiosis ...
Status
Completed
Location
The First Affiliated Hospital, College of Medicine, Zhejiang University
Start Date
2019-11-24
Trial ID
NCT05687409
This is a randomized, open-labelled, prospective 96-week study comparing th...
Status
Completed
Location
Pusan National University School of Medicine
Start Date
2008-02
Trial ID
NCT00637663
Treatments Being Tested
Patients with chronic hepatitis B who are undergoing anticancer chemotherap...
Status
Completed
Location
National Cancer Center, Korea
Start Date
2012-04
Trial ID
NCT01580202
Treatments Being Tested
Abstract Telbivudine is a potent inhibitor of HBV but, due to a low geneti...
Status
Unknown
Location
Liver clinic
Start Date
2010-03
Trial ID
NCT01083251
Treatments Being Tested